Featured Research

from universities, journals, and other organizations

Scientists Tweak Cervical Cancer Vaccine Technology To Fight Most Common Sexually Transmitted Disease -- Genital Warts

Date:
February 14, 2006
Source:
University of Queensland
Summary:
The technology used in the world's first cervical cancer vaccine will be tweaked to fight the most common sexually transmitted disease, genital warts. The vaccine used virus-like particles to deliver an antigen (protein that produces immunity) for genital warts similar to the cervical cancer vaccine.

The technology used in the world's first cervical cancer vaccine will be tweaked to fight the most common sexually transmitted disease, genital warts.

Australian of the Year and University of Queensland (UQ) cervical cancer vaccine creator Professor Ian Frazer recently launched a therapeutic vaccine trial for genital warts (Tuesday, February 7).

Patients from Brisbane and China will take part in the joint project for UQ's cancer research centre, the Centre for Immunology and Cancer Research (CICR) and the hospital's sexual health service, Princess Alexandra Sexual Health (PASH).

Professor Frazer said the vaccine used virus-like particles to deliver an antigen (protein that produces immunity) for genital warts similar to the cervical cancer vaccine.

"It will target the main causes of visible genital warts which are human papillomavirus (HPV6) and (HPV11)," Dr Frazer said.

A pilot study of vaccine CICRVAX6 by UQ's Chinese research partner, Wenzhou Medical College, showed the vaccine was potentially effective at treating genital warts in humans.

Now PASH is running a larger trial and needs 120 men and 120 women who have recurring genital warts.

Participants must be aged between 18 and 65 years, should not be pregnant or immunosuppressed and will be required for seven medical visits, with their travel costs refunded.

Trial Manager and PASH Senior Medical Officer Dr David Jardine said patients would receive standard treatment for genital warts and two vaccine shots, which are saline solutions injected in the upper arm, over two months.

"The incentives for people are that they get free consultations, free treatment, free vaccines and their travelling expenses paid," Dr Jardine said.

He said conventional wart treatments of freezing, burning or painting visible warts with acid might not switch off the active infection.

The 18-month trial will be launched in conjunction with Wartfest, an annual expo about new developments and treatments for warts, HPV and cancer, featuring expert speakers from Australia and Canada.

Genital warts are transmitted by skin contact and the 2003 Australian Study of Sex and Relationships of 20,000 adults revealed four percent of people had had visible genital warts.

Professor Frazer said developing a preventative warts vaccine or a combined vaccine for cervical cancer and genital warts was one of the next steps if the therapeutic trial was successful.

###

For more details about Wartfest, visit: http://www.cicr.uq.edu.au/



Story Source:

The above story is based on materials provided by University of Queensland. Note: Materials may be edited for content and length.


Cite This Page:

University of Queensland. "Scientists Tweak Cervical Cancer Vaccine Technology To Fight Most Common Sexually Transmitted Disease -- Genital Warts." ScienceDaily. ScienceDaily, 14 February 2006. <www.sciencedaily.com/releases/2006/02/060213104113.htm>.
University of Queensland. (2006, February 14). Scientists Tweak Cervical Cancer Vaccine Technology To Fight Most Common Sexually Transmitted Disease -- Genital Warts. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2006/02/060213104113.htm
University of Queensland. "Scientists Tweak Cervical Cancer Vaccine Technology To Fight Most Common Sexually Transmitted Disease -- Genital Warts." ScienceDaily. www.sciencedaily.com/releases/2006/02/060213104113.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins